Genzyme shares rise on buyout speculation – BusinessWeek
By Dr. Matthew Watson
 Globe and Mail | Genzyme shares rise on buyout speculation BusinessWeek Shares of Genzyme Corp. rose Monday following speculation that Sanofi-Aventis is interested in buying the biotechnology company. THE SPARK: On Friday, ... Biotechnology Stocks Posting Strong Gains In Late-Morning DealingRTT News Genzyme weighs Sanofi approach: sourceReuters Biogen Shares Rise on Biotech Buyout SpeculationABC News Wall Street Journal (blog) -Bloomberg -ETF Trends (blog) all 231 news articles » |
Uncategorized
Comments Off on Genzyme shares rise on buyout speculation – BusinessWeek |
July 28th, 2010
This author published 5872 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research